Scientific Sessions 2025  /  Multimorbidity: Hypertension, Hyperlipidemia and Cardiovascular Disease  /  Case Study 1 Facilitiation for Multimorbidity: Hypertension, Hyperlipidemia and Cardiovascular Disease
Logo

American Heart Association

  38
  0

Final ID:

Case Study 1 Facilitiation for Multimorbidity: Hypertension, Hyperlipidemia and Cardiovascular Disease

  • Plutzky, Jorge  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    Jorge Plutzky: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Consultant:Toku:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Multimorbidity: Hypertension, Hyperlipidemia and Cardiovascular Disease

Friday, 11/07/2025 , 03:10PM - 04:00PM

Cardiovascular Seminar

More abstracts on this topic:
Discuss Case Study 1 in Breakout Groups

Joseph Joshua, Khan Sadiya, Ndumele Chiadi, Lala-trindade Anuradha, Vest Amanda, Vardeny Orly, Powell-wiley Tiffany, Modarressi Taher, Pagidipati Neha, Magwire Melissa, Rangaswami Janani

More abstracts from these authors:
Semaglutide Improves Cardiovascular Outcomes in Patients with a History of Coronary Artery Bypass Surgery and Overweight or Obesity: The SELECT Trial

Verma Subodh, Lincoff Abraham, Emerson Scott, Plutzky Jorge, Kahn Steven, Stensen Signe, Weeke Peter, Rasmussen Soren, Poirier Paul, Lingvay Ildiko

SELECT-LIFE: A non-interventional follow-up study investigating the long-term effects of semaglutide in participants from the SELECT trial

Lingvay Ildiko, Deanfield John, De Los Angeles Quiroga Pelaez Maria, Kahn Steven, Lincoff Abraham, Plutzky Jorge, Ross Stine, Weeke Peter, Ryan Donna

You have to be authorized to contact abstract author. Please, Login
Not Available